CANY
DRNA

Caxton Associates (New York)’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History

Caxton Associates (New York)’s Portfolio DRNA Stock Details DRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-24,733
Closed -$628K – 549
2020
Q2 		$628K Buy
24,733
+12,311
+99% +$313K 0.05% 92
2020
Q1 		$228K Sell
12,422
-11,566
-48% -$212K 0.04% 316
2019
Q4 		$528K Buy
+23,988
New +$528K 0.07% 160